XENOPAX PLUS INTRAOPERATIVE STEROID IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY (AASLD 2026) - Oct 6, 2026 - Abstract #4416; Pres time: Nov 8, 2026; 01:00 PM - 02:00 PM; Location: Convention Center: Poster Hall, Hall DE; "Xenopax plus intraoperative steroids provides non‑inferior ACR prophylaxis relative to basiliximab in pediatric LT, with a favorable safety profile marked by lower pulmonary infection risk—especially in patients with CIT > 90 minutes. Patients with CIT ≤90 minutes may derive particular benefit for rejection prevention. This regimen is a promising induction strategy for pediatric liver transplantation."
Retrospective data • Cardiovascular • Infectious Disease • Pediatrics • Respiratory Diseases • Transplantation • IL2
|